Further knockout of SLAMF8 revealed inhibition of TLR4 expression, blocking NF-κB signaling in the RA model, ultimately alleviating synovial hyperplasia and arthritis in mice (Liu et al., 2022). The gene discussed is SLAMF8; the disease is rheumatoid arthritis.